Venous thromboembolic complications
https://doi.org/10.24884/0042-4625-2019-178-1-77-81
Abstract
The article is devoted to the current issues of diagnosis of deep vein thrombosis of the lower extremities, provides updated recommendations on the choice of drugs in the treatment of deep vein thrombosis of the lower extremities in various clinical situations
About the Authors
G. G. Khubulava
Military Medical Academy named after S. M. Kirov
Russian Federation
Russian Federation
Gennadii G. Khubulava
St. Petersburg
E. K. Gavrilov
Military Medical Academy named after S. M. Kirov
Russian Federation
Corresponding author: Evgenii K. Gavrilov, Military Medical Academy named after S. M. Kirov, 6 Academika Lebedeva street, St. Petersburg, Russia,194044
Russian Federation
Corresponding author: Evgenii K. Gavrilov, Military Medical Academy named after S. M. Kirov, 6 Academika Lebedeva street, St. Petersburg, Russia,194044
H. L. Bolotokov
Military Medical Academy named after S. M. Kirov
Russian Federation
Russian Federation
Hazhmurat L. Bolotokov
St. Petersburg
S. V. Sadovoy
Military Medical Academy named after S. M. Kirov
Russian Federation
Russian Federation
Sergei V. Sadovoi
St. Petersburg
References
1. Rossiiskie klinicheskie rekomendatsii po diagnostike, lecheniyu i profilaktike venoznykh tromboembolicheskikh oslozhnenii (VTEO). Flebologiya. 2015. Vol. 9, № 4, pp. 1–52. (In Russ.).
2. Gloviczki P. Handbook of venous and lymphatic disorders, 4th ed. Guidelines of the American Venous Forum. Boca Raton : Taylor & Francis Group, 2017. P. 838.
3. Robertson L., Kesteven P., McCaslin J. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis (Review) // Cochrane Database of Sysematic Reviews. 2015, Is. 6. Art. No.: CD010956.
4. Van Beek E., Buller H., Oudkerk M. Deep vein thrombosis and pulmonary embolism. Chichester : John Wiley & Sons, Ltd., 2009. P. 564.
5. Kearon C., Akl E., Comerota A. et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis. 9th ed. : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines // Chest. 2012. Vol. 141, № 2. Suppl. P. e419S–96S.
6. National Institute for Health and Care Excellence. Venous thromboembolic diseases : the management of thromboembolic diseases and the role of thrombophilia testing, 2012. URL: http://nice.org.uk/guidance/cg144 (дата обращения 11.01.2019).
7. Kearon C., Akl E., Ornelas J. et al. Antithrombotic Therapy for VTE Disease : CHEST guideline and expert panel report // Chest. 2016. Vol. 149, № 2. P. 315–352.
8. Othieno R., Okpo E., Forster R. Home versus in-patient treatment for deep vein thrombosis (Review) // Cochrane Database of Systematic Reviews. 2018. Is. 1. Art. No.: CD003076.
9. Kataruka A., Kong X., Haymart B. et al. SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism : the MAQI2 experience // Vasc. Med. 2017. Vol. 22, № 3. P. 197–203.
10. Jacobs B., Henke P. Evidence-based therapies for pharmacologic prevention and treatment of acute deep vein thrombosis and pulmonary embolism // Surgical Clinics of North America. 2018. Vol. 98, № 2.P. 239–253. URL: https://www.ncbi.nlm.nih.gov/pubmed/29502769 (дата обращения 11.01.2019).
11. New trends in anticoagulation therapy / M. Smith, G. Wakam, T. Wakefield, A. Obi // Surg. Clin. N. Am. 2018. Vol. 98. P. 219–238.
12. Hubulava G. G., Gavrilov E. K., SHishkevich A. N. Flotiruyushchie flebotrombozy nizhnih konechnostej – sovremennye podhody k hirurgicheskomu lecheniyu. Vestnik khirurgii imeni I. I. Grekova. 2015. Vol. 173, № 4, pp. 111–115. (In Russ.). Doi: doi.org/10.24884/0042-4625-2014-173-4-111-115.
Review
For citations:
Khubulava G.G., Gavrilov E.K., Bolotokov H.L., Sadovoy S.V. Venous thromboembolic complications. Grekov's Bulletin of Surgery. 2019;178(1):77-81. (In Russ.) https://doi.org/10.24884/0042-4625-2019-178-1-77-81
Views:
818
Email this article 